James A. Schoeneck
2012 - DepoMed
In 2012, James A. Schoeneck earned a total compensation of $1.7M as President and Chief Executive Officer at DepoMed, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $304,500 |
|---|---|
| Option Awards | $363,248 |
| Salary | $567,000 |
| Stock Awards | $419,757 |
| Other | $72,666 |
| Total | $1,727,171 |
Schoeneck received $567K in salary, accounting for 33% of the total pay in 2012.
Schoeneck also received $304.5K in non-equity incentive plan, $363.2K in option awards, $419.8K in stock awards and $72.7K in other compensation.
Rankings
In 2012, James A. Schoeneck's compensation ranked 4,052nd out of 11,487 executives tracked by ExecPay. In other words, Schoeneck earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,052 out of 11,487 | 65th |
Division Manufacturing | 1,401 out of 4,253 | 67th |
Major group Chemicals And Allied Products | 317 out of 1,203 | 74th |
Industry group Drugs | 191 out of 925 | 79th |
Industry Pharmaceutical Preparations | 146 out of 700 | 79th |
Source: SEC filing on April 6, 2015.
Schoeneck's colleagues
We found four more compensation records of executives who worked with James A. Schoeneck at DepoMed in 2012.